Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04239209 · ClinicalTrials.gov registry record · NA

Effect of Intensivist Communication on Surrogate Prognosis Interpretation

A NA study of Critical Illness, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
302
Enrollment target
1
Study location

NCT04239209 is a NA study of Critical Illness that has completed, run by Johns Hopkins University. The registered enrollment target is 302 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04239209, a NA study of Critical Illness, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
302 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to die.

Conditions Studied

Interventions

  • BEHAVIORAL Indirect - other patients
  • BEHAVIORAL Indirect - physiology
  • BEHAVIORAL Redirection
  • BEHAVIORAL Direct communication

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 302 participants
Start Date 2019-09-27
Est. Completion 2019-10-17
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT04239209

The ClinicalTrials.gov registry entry for NCT04239209 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 4 interventions - of which Indirect - other patients is the first listed.

NCT04239209 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04239209 about?

NCT04239209 is a clinical study titled "Effect of Intensivist Communication on Surrogate Prognosis Interpretation". This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to d...

What is the current status of trial NCT04239209?

This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2019-09-27. Estimated completion is 2019-10-17.

What conditions does trial NCT04239209 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT04239209?

The interventions under investigation include: Indirect - other patients (BEHAVIORAL), Indirect - physiology (BEHAVIORAL), Redirection (BEHAVIORAL), Direct communication (BEHAVIORAL).

Who is sponsoring clinical trial NCT04239209?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04239209 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.